AI-powered tools enable faster stroke diagnosis and treatment within the critical golden hour in IndiaArtificial intelligence is revolutionizing stroke care in India by accelerating diagnosis and treatment within the critical "golden hour." ...
14 Dec, 2025, 04.57 PM IST
Vitamin K: The unsung hero for blood, bones, and heart health. Here's check symptoms of its deficiency, causes, and how to prevent itVitamin K, often overlooked, is vital for blood clotting, bone strength, and heart health. Deficiency, more common than thought, can lead t...
13 Nov, 2025, 06.06 PM IST
Exploring the benefits of this ancient Chinese therapy still thriving todayGua sha, a 2,000-year-old Chinese therapeutic scraping technique, is gaining recognition for its potential health benefits. It involves scr...
04 Oct, 2025, 01.34 AM IST
The estrogen nobody told you about is changing hormone care — here’s why it matters nowEstrogen hormone therapy: A new estrogen called Estetrol or E4 is gaining attention. It is produced during pregnancy. Unlike other estrogen...
26 Jul, 2025, 08.17 AM IST
NBA Hall of Famer Charles Barkley doesn't buy into Victor Wembanyama's hype, feels he can't be the league's faceVictor Wembanyama was diagnosed with deep vein thrombosis earlier this week and will miss the rest of the season. Former America forward Ch...
22 Feb, 2025, 01.28 AM IST
Spurs star Victor Wembanyama ruled out for rest of NBA season due to deep vein thrombosisSan Antonio Spurs’ star Victor Wembanyama will miss the rest of the season due to deep vein thrombosis in his right shoulder. The 7’3” rook...
21 Feb, 2025, 01.46 AM IST
59-year-old man suffering from Guillain-Barre Syndrome dies in Pune, death toll in city hits eightA 59-year-old man diagnosed with Guillain-Barré Syndrome (GBS) has passed away in Pune, marking the eighth death due to the rare neurologic...
12 Feb, 2025, 07.51 PM IST
Pune GBS cases: A 37-year-old man dies in Pune; toll touches 7A 37-year-old man diagnosed with Guillain-Barre Syndrome died in Pune, bringing the toll to seven. The condition, often triggered by bacter...
10 Feb, 2025, 09.30 PM IST
GBS cases rise: What are key symptoms? Is it deadly? Can it be treated? Here is all about the syndromeA 40-year-old man suspected of having Guillain-Barre Syndrome (GBS) died in Solapur, Maharashtra. Over 100 cases of GBS have been reported ...
27 Jan, 2025, 05.19 PM IST
Artificial sweetners in chewing gum and even toothpaste can give you blood clots, heart attacks or stroke: StudyArtificial sweeteners, particularly xylitol, may pose health risks by affecting platelets and blood clotting, leading to cardiovascular eve...
08 Jun, 2024, 10.25 AM IST
Two years after suffering a crippling stroke, Sinbad now on path to miraculous recovery. See detailsThe family is incredibly appreciative of this miracle. The news was announced two years after Sinbad suffered an ischemic attack, according...
23 Nov, 2022, 01.04 AM IST
Risk of blood clots in lung doubled for Covid survivors: US studyThe research by the Centers for Disease Control and Prevention found that as many as one in five adults aged 18-64 years and one in four of...
25 May, 2022, 08.35 AM IST
Low-cost blood thinning drug may potentially treat, prevent COVID-19: StudyThe initial results from 98 patients, published in the British Journal of Clinical Pharmacology, indicate that heparin could be a promising...
07 Feb, 2022, 05.21 PM IST
All the Covid-19 symptoms you didn’t know aboutCovid is now emerging as a pathogen capable of harming in a myriad of unexpected, and sometimes lethal, ways.
12 May, 2020, 09.11 PM IST
Newly-developed 'injectable bandage' may help heal fatal, internal injuriesThe therapeutic gel can stop bleeding and promote wound healing.
03 Apr, 2018, 06.43 PM IST
CCI clears Abbott-St Jude deal subject to 'voluntary remedies'In a tweet, Competition Commission of India (CCI) said it has approved the "proposed combination between St Jude Medical and Abbott Laborat...
18 Dec, 2016, 12.25 PM IST
- Ranbaxy Labs enters deal CD Pharma to market INERSAN
Ranbaxy Laboratories has entered into an exclusive in-licensing agreement with CD Pharma to market the INERSAN brand in India and Nepal.
18 Mar, 2008, 12.59 PM IST